Immunogenicity and safety of currently available Japanese encephalitis vaccines: a systematic review.
Hum Vaccin Immunother
; 10(12): 3579-93, 2014.
Article
en En
| MEDLINE
| ID: mdl-25668666
Palabras clave
ACIP, The Advisory Committee on Immunization Practices; AEs, Adverse events; CENTRAL, Cochrane Central Register of Controlled Trials; CIs, Confidence intervals; DARE, Database of Abstracts of Reviews of Effects; GMTs, Geometric mean titers; HAART, Highly active antiretroviral therapy; JE, Japanese encephalitis; JE-CV, Chimeric live-attenuated JE vaccine; JEV, Japanese encephalitis virus; Japanese encephalitis vaccine; LILACS, Latin American and Caribbean Health Sciences Literature; MBJEV, Mouse brainderived inactivated vaccines; MMR, Measles mumps rubella vaccine; NIP, National Immunization Program; NOS, NewcastleOttawa scale; ORs, Odd ratios; PHK, Primary hamster kidney cells; PRNT50, Plaque-reduction neutralization tests; RCTs, Randomized controlled trials; TBE, Tick-borne encephalitis vaccine; TGPO, Thai Governmental Pharmaceutical Organization; WHO, World Health Organization; YF-VAX, Yellow fever vaccine; YFV, Yellow fever virus; YFV17D, Yellow fever virus 17D vaccine strain; immunogenicity; meta-analysis; safety; systematic review
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Vacunas contra la Encefalitis Japonesa
Tipo de estudio:
Prognostic_studies
/
Systematic_reviews
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Hum Vaccin Immunother
Año:
2014
Tipo del documento:
Article
País de afiliación:
China